Zoccali C - Search Results

1

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C. Ferro CJ, et al. Among authors: zoccali c. Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Nat Rev Nephrol. 2018. PMID: 30361677 Free article. Review.

2

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Zoccali C, et al. J Am Soc Nephrol. 2002 Jan;13(1):134-141. doi: 10.1681/ASN.V131134. J Am Soc Nephrol. 2002. PMID: 11752030

3

Nocturnal hypoxemia: a neglected cardiovascular risk factor in end-stage renal disease?

Zoccali C, Mallamaci F, Tripepi G. Zoccali C, et al. Blood Purif. 2002;20(1):120-3. doi: 10.1159/000046995. Blood Purif. 2002. PMID: 11803169 Review.

4

Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease.

Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Salvatore Malatino L, Böger R. Zoccali C, et al. J Am Soc Nephrol. 2002 Feb;13(2):490-496. doi: 10.1681/ASN.V132490. J Am Soc Nephrol. 2002. PMID: 11805179

5

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.

Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A; CREED Investigators. Mallamaci F, et al. Among authors: zoccali c. Kidney Int. 2002 Feb;61(2):609-14. doi: 10.1046/j.1523-1755.2002.00144.x. Kidney Int. 2002. PMID: 11849403 Free article.

6

Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients.

Zoccali C, Mallamaci F, Tripepi G. Zoccali C, et al. J Am Soc Nephrol. 2002 Mar;13(3):729-733. doi: 10.1681/ASN.V133729. J Am Soc Nephrol. 2002. PMID: 11856778

7

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS. Zoccali C, et al. Circulation. 2002 Mar 19;105(11):1354-9. doi: 10.1161/hc1102.105261. Circulation. 2002. PMID: 11901048

8

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.

Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Böger R; CREED Investigators. Zoccali C, et al. Kidney Int. 2002 Jul;62(1):339-45. doi: 10.1046/j.1523-1755.2002.00437.x. Kidney Int. 2002. PMID: 12081596 Free article.

9

Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, Bonanno G, Fatuzzo P, Rapisarda F, Seminara G, Stancanelli B, Bellanuova I, Cataliotti A, Malatino LS. Mallamaci F, et al. Among authors: zoccali c. Am J Kidney Dis. 2002 Jul;40(1):68-75. doi: 10.1053/ajkd.2002.33914. Am J Kidney Dis. 2002. PMID: 12087563

10

Norepinephrine and concentric hypertrophy in patients with end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Cataliotti A, Malatino LS; CREED investigators. Zoccali C, et al. Hypertension. 2002 Jul;40(1):41-6. doi: 10.1161/01.hyp.0000022063.50739.60. Hypertension. 2002. PMID: 12105136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,004 results

Search Page